STOCK TITAN

Conduent (CNDT) Stock News

CNDT Nasdaq

Welcome to our dedicated page for Conduent news (Ticker: CNDT), a resource for investors and traders seeking the latest updates and insights on Conduent stock.

Conduent Incorporated reports developments for a global technology-driven business solutions and services company serving commercial, government and transportation clients. News commonly covers operating results, new business activity, cost and efficiency programs, and digital process services built around cloud computing, artificial intelligence, machine learning, automation and analytics.

Company updates also address GenAI-enabled finance and procurement tools such as FastCap, healthcare payer operations supported by Health Solutions Plus, HR service modernization, electronic benefits transfer security, tolling services and public-sector payment programs. Governance announcements, including board and senior leadership changes, are recurring corporate news themes for CNDT.

Rhea-AI Summary

Conduent (Nasdaq: CNDT) has finalized the sale of its Midas Suite of Solutions to symplr for $340 million, resulting in net proceeds of approximately $270 million for the company. These funds will be utilized for debt repayment and further investments in its business. This transaction aligns with Conduent’s strategy to maximize synergies within its portfolio to boost shareholder and client value. The company remains committed to providing healthcare solutions that enhance member experiences, automate claims, and streamline operations, serving 75% of U.S. insured patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.78%
Tags
none
-
Rhea-AI Summary

Conduent (NASDAQ: CNDT) has secured a five-year agreement to provide health plan management services for the Uniformed Services Family Health Plan (USFHP) at Saint Vincents Catholic Medical Center. This selection follows a competitive bid process and emphasizes scalable solutions in claims processing, member engagement, and fulfillment. USFHP serves military families in the Northeastern U.S. and chose Conduent for its proven expertise and ability to adapt to the evolving healthcare landscape. This partnership aims to enhance operational efficiency and member health outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
none
-
Rhea-AI Summary

Conduent Incorporated (Nasdaq: CNDT) will announce its fourth quarter and full year 2021 financial results on February 16, 2022, post-market close. A conference call will follow at 5:00 p.m. ET to discuss the results. Interested parties can access the call via a live audio webcast or dial-in options. Conduent provides critical services to businesses and governments, improving workflow and efficiency, with significant impacts on operations for clients, including Fortune 100 companies and various government entities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
conferences earnings
Rhea-AI Summary

Conduent (CNDT) has been named a 'Rising Star' in the 2021 ISG Provider Lens™ Healthcare Digital Services Report by ISG, a technology research firm. It received this recognition for its strong portfolio in Payer Digital Transformation Services and Payer Business Process as a Service (BPaaS). The report highlighted Conduent's end-to-end capabilities that enhance member engagement and improve healthcare outcomes. Additionally, the company was recognized as a 'Product Challenger' in Healthcare Interoperability Services & Solutions, showcasing its investment in market presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.14%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
none
Rhea-AI Summary

Conduent (Nasdaq: CNDT) has announced a definitive agreement to sell its Midas Suite of Solutions to symplr for $340 million in cash. The Midas suite, generating $72 million in 2020 revenue, supports approximately 2,200 healthcare facilities. This divestiture aligns with Conduent's strategy to streamline operations and enhance shareholder value, with a focus on a smooth transition for clients and team members. The transaction is set to close in the first quarter of 2022, pending regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.61%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.01%
Tags
none
-
Rhea-AI Summary

Conduent announced a new agreement with the North Dakota Department of Human Services (ND DHS) to enhance the technology for its Medicaid Management Information System (MMIS). This upgrade aims to modernize the full technology stack, improving system reliability, scalability, and security. As a trusted partner, Conduent will help ND DHS better serve over 300,000 North Dakotans. With 50 years of experience, Conduent supports Medicaid systems in various states and has achieved federal MMIS certifications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Conduent's Maven® has been selected as the new Case and Incident Management System (CIMS) for the UK Health Security Agency (UKHSA), replacing the existing system. This transition aims to bolster public health responses following the COVID-19 pandemic. Maven will initially track acute respiratory infections, including COVID-19, with expansion planned for other diseases by winter 2022. The platform promises advanced configurability, efficient data entry, and streamlined workflows. Conduent, with nearly 40 years in public service, aims to enhance health monitoring and response capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.7%
Tags
none

FAQ

What is the current stock price of Conduent (CNDT)?

The current stock price of Conduent (CNDT) is $1.57 as of July 31, 2026.

What is the market cap of Conduent (CNDT)?

The market cap of Conduent (CNDT) is approximately 245.1M.